SoftWeb

Cision PR Newswire | August 21, 2020

Siemon, a leading global network infrastructure specialist, today announced its new LockIT™ system category 6 and category 6A patch cords that prevent unintended or unauthorized disconnections in a network. Siemon's LockIT patch cords available in shielded and unshielded category 6A and unshielded category 6 can be freely inserted into an RJ45 outlet at end device locations or patch panels but require the included LockIT Cord Key for removal. They are ideal for preventing disconnection...

Application Infrastructure

Mavenir | March 04, 2022

Mavenir, the Network Software Provider building the future of networks with cloud-native software that runs on any cloud and transforms the way the world connects, today announced a collaboration with Qualcomm Technologies, Inc. to expand its OpenBeamTM Open RAN portfolio of 5G Radio Units (RU) spanning categories ranging from mmWave to Massive MIMO with 64T64R capabilities to 8T8R radios to drive the transition towards modern networks. In addition, Mavenir plans to develop vDU RAN software base...

Hyper-Converged Infrastructure,Application Infrastructure,Data Storage

Liftr Insights | November 11, 2022

Liftr Insights, a pioneer in market intelligence driven by unique data, shows strength within NVIDIA's business. Recent disappointing activity with NVIDIA has drawn many eyes, but a deeper dive shows that one of their business units has remained strong while others have faltered. That part? Data center revenue. NVIDIA data center revenue revolves around GPU accelerators sold to public and private cloud centers. Public cloud providers continue to g...

Application Infrastructure

Simulations Plus | January 16, 2023

Simulations Plus, Inc. recently announced that its DILIsym Services (DSS) division released DILIsym® version X (DSX) Beta, the latest iteration of its flagship quantitative systems toxicology (QST) software for predicting and investigating drug-induced liver injury (DILI). DILIsym modeling aids vital drug development decisions by prevising the potential DILI risk of new drug candidates. The modeling also identifies the biochemical events that contribute to DILI caused by a med...